The aim of this brief report is to raise awareness of necrotizing soft-tissue infections caused by Clostridium tetani in intravenous drug users, highlight the potentially unique dangers of this infection in this specific patient population, and outline the course of treatment currently considered the standard of care.
Get full access to this article
View all access options for this article.
References
1.
U.S. Centers for Disease Control and Prevention. Tetanus surveillance—United States 2001–2008. Morbid Mortal Wkly Rep, 2011; 60:365–369.
2.
LevinsonA, MarskeRL, SheinMK. Tetanus in heroin addicts. JAMA, 1955; 157:658–660.
MoneyS, GarberB. Infections in the injection drug abuser. Curr Emerg Hosp Med Rep, 2018; 6:157–161.
5.
El-MenyarA, AsimM, MudaliIN, et al.The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scoring: The diagnostic and potential prognostic role. Scand J Trauma Resusc Emerg Med, 2017; 25:28.
6.
VugiaDJ, WernerSB, WoodfillCJ. Wound botulism, tetanus and necrotizing fasciitis among injecting drug users in California: The clostridial connection. Emerg Infect, 2004; 6:111–120.
7.
GordonRJ, LowyFD. Bacterial infections in drug users. N Engl J Med, 2005; 353:1945–1954.
8.
BeechingNJ. Tetanus in injecting drug users: The latest clostridium infection to threaten injectors in Britain. BMJ, 2005; 330:208–209.
9.
CherubinCE. Epidemiology of tetanus in narcotic addicts. NY State J Med, 1970; 70:267–271.
10.
BarsamA, KerinsM, JayeP. Tetanus and intravenous drug use. Eur J Clin Microbiol Infect Dis, 2005; 24:497–498.
11.
SunKO, ChanYW, CheungRT, et al.Management of tetanus: A review of 18 cases. J R Soc Med, 1994; 87:135–137.
12.
BaddourLM, BrownAM. Infectious complications of puncture wounds. UpToDate, 2019.
